메뉴 건너뛰기




Volumn 61, Issue 8, 2012, Pages 1067-1072

Pravastatin inhibits advanced glycation end products (AGEs)-induced proximal tubular cell apoptosis and injury by reducing receptor for AGEs (RAGE) level

Author keywords

Ab; Ab raised against RAGE; ADMA; advanced glycation end products; AGEs; antibody; asymmetric dimethylarginine; bovine serum albumin; BSA; chronic kidney disease; CKD; DDAH2; DHE; dihydroethidium; dimethylarginine dimethylaminohydrolase 2; geranylgeranyl pyrophosphate; GGPP; RAGE; RAGE Ab; reactive oxygen species; receptor for AGEs; reverse transcription polymerase chain reactions; ROS; RT PCR; SEM; standard error

Indexed keywords

ADVANCED GLYCATION END PRODUCT; DIMETHYLARGININASE; DIMETHYLARGININE DIMETHYLAMINOHYDROLASE 2; GERANYLGERANYL PYROPHOSPHATE; HYDROETHIDINE; MESSENGER RNA; N(G),N(G) DIMETHYLARGININE; PRAVASTATIN; REACTIVE OXYGEN METABOLITE; ROSUVASTATIN; UNCLASSIFIED DRUG;

EID: 84864287672     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2012.01.006     Document Type: Article
Times cited : (74)

References (20)
  • 1
    • 0028272883 scopus 로고
    • Pathogenic effects of advanced glycosylation: Biochemical, biologic, and clinical implications for diabetes and aging
    • H. Vlassara, R. Bucala, and L. Striker Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging Lab. Invest 70 1994 138 151 (Pubitemid 24090096)
    • (1994) Laboratory Investigation , vol.70 , Issue.2 , pp. 138-151
    • Vlassara, H.1    Bucala, R.2    Striker, L.3
  • 2
    • 73249122895 scopus 로고    scopus 로고
    • RAGE, glomerulosclerosis and proteinuria: Roles in podocytes and endothelial cells
    • V. D'Agati, S.F. Yan, and R. Ramasamy RAGE, glomerulosclerosis and proteinuria: roles in podocytes and endothelial cells Trends Endocrinol. Metab. 21 2010 50 56
    • (2010) Trends Endocrinol. Metab. , vol.21 , pp. 50-56
    • D'Agati, V.1    Yan, S.F.2    Ramasamy, R.3
  • 3
    • 21044443182 scopus 로고    scopus 로고
    • Diabetic vascular complications: Pathophysiology, biochemical basis and potential therapeutic strategy
    • DOI 10.2174/1381612054367300
    • S. Yamagishi, and T. Imaizumi Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy Curr. Pharm. Des. 11 2005 2279 2299 (Pubitemid 40872698)
    • (2005) Current Pharmaceutical Design , vol.11 , Issue.18 , pp. 2279-2299
    • Yamagishi, S.-I.1    Imaizumi, T.2
  • 4
    • 38449119409 scopus 로고    scopus 로고
    • Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: The Treating to New Targets (TNT) study
    • J. Shepherd, J.J. Kastelein, and V. Bittner Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study Clin. J. Am. Soc. Nephrol. 2 2007 1131 1139
    • (2007) Clin. J. Am. Soc. Nephrol. , vol.2 , pp. 1131-1139
    • Shepherd, J.1    Kastelein, J.J.2    Bittner, V.3
  • 5
    • 49749144405 scopus 로고    scopus 로고
    • Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney disease
    • L.F. Fried Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney disease Kidney Int. 74 2008 571 576
    • (2008) Kidney Int. , vol.74 , pp. 571-576
    • Fried, L.F.1
  • 6
    • 17444384875 scopus 로고    scopus 로고
    • The acute effect of atorvastatin on proteinuria in patients with chronic glomerulonephritis
    • R.C. Ozsoy, M.G. Koopman, and J.J. Kastelein The acute effect of atorvastatin on proteinuria in patients with chronic glomerulonephritis Clin. Nephrol. 63 2005 245 249 (Pubitemid 40542383)
    • (2005) Clinical Nephrology , vol.63 , Issue.4 , pp. 245-249
    • Ozsoy, R.C.1    Koopman, M.G.2    Kastelein, J.J.P.3    Arisz, L.4
  • 7
    • 0041468953 scopus 로고    scopus 로고
    • Atorvastatin reduces microalbuminuria in patients with familial hypercholesterolemia and normal glucose tolerance
    • H. Sinzinger, H. Kritz, and C.D. Furberg Atorvastatin reduces microalbuminuria in patients with familial hypercholesterolemia and normal glucose tolerance Med. Sci. Monit. 9 2003 PI88 PI92
    • (2003) Med. Sci. Monit. , vol.9
    • Sinzinger, H.1    Kritz, H.2    Furberg, C.D.3
  • 9
    • 77953794875 scopus 로고    scopus 로고
    • Pravastatin attenuates carboplatin-induced nephrotoxicity in rodents via peroxisome proliferator-activated receptor alpha-regulated heme oxygenase-1
    • H.H. Chen, T.W. Chen, and H. Lin Pravastatin attenuates carboplatin-induced nephrotoxicity in rodents via peroxisome proliferator-activated receptor alpha-regulated heme oxygenase-1 Mol. Pharmacol. 78 2010 36 45
    • (2010) Mol. Pharmacol. , vol.78 , pp. 36-45
    • Chen, H.H.1    Chen, T.W.2    Lin, H.3
  • 10
    • 49249134599 scopus 로고    scopus 로고
    • Statins restore ischemic limb blood flow in diabetic microangiopathy via eNOS/NO upregulation but not via PDGF-BB expression
    • T. Fujii, M. Onimaru, and Y. Yonemitsu Statins restore ischemic limb blood flow in diabetic microangiopathy via eNOS/NO upregulation but not via PDGF-BB expression Am. J. Physiol. Heart Circ. Physiol. 294 2008 H2785 H2791
    • (2008) Am. J. Physiol. Heart Circ. Physiol. , vol.294
    • Fujii, T.1    Onimaru, M.2    Yonemitsu, Y.3
  • 12
    • 79751527695 scopus 로고    scopus 로고
    • Pigment epithelium-derived factor (PEDF) inhibits proximal tubular cell injury in early diabetic nephropathy by suppressing advanced glycation end products (AGEs)-receptor (RAGE) axis
    • S. Maeda, T. Matsui, and M. Takeuchi Pigment epithelium-derived factor (PEDF) inhibits proximal tubular cell injury in early diabetic nephropathy by suppressing advanced glycation end products (AGEs)-receptor (RAGE) axis Pharmacol. Res. 63 2010 241 248
    • (2010) Pharmacol. Res. , vol.63 , pp. 241-248
    • Maeda, S.1    Matsui, T.2    Takeuchi, M.3
  • 13
    • 77955414324 scopus 로고    scopus 로고
    • Pigment epithelium-derived factor inhibits advanced glycation end product-elicited mesangial cell damage by blocking NF-kappaB activation
    • Y. Ide, T. Matsui, and Y. Ishibashi Pigment epithelium-derived factor inhibits advanced glycation end product-elicited mesangial cell damage by blocking NF-kappaB activation Microvasc. Res. 80 2010 227 232
    • (2010) Microvasc. Res. , vol.80 , pp. 227-232
    • Ide, Y.1    Matsui, T.2    Ishibashi, Y.3
  • 14
    • 33751171940 scopus 로고    scopus 로고
    • Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes
    • C. Cuccurullo, A. Iezzi, and M.L. Fazia Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes Arterioscler. Thromb. Vasc. Biol. 26 2006 2716 2723
    • (2006) Arterioscler. Thromb. Vasc. Biol. , vol.26 , pp. 2716-2723
    • Cuccurullo, C.1    Iezzi, A.2    Fazia, M.L.3
  • 15
    • 77649291952 scopus 로고    scopus 로고
    • Pravastatin counteracts angiotensin II-induced upregulation and activation of NADPH oxidase at plasma membrane of human endothelial cells
    • E. Alvarez, B.K. Rodiño-Janeiro, and R. Ucieda-Somoza Pravastatin counteracts angiotensin II-induced upregulation and activation of NADPH oxidase at plasma membrane of human endothelial cells J. Cardiovasc. Pharmacol. 55 2010 203 212
    • (2010) J. Cardiovasc. Pharmacol. , vol.55 , pp. 203-212
    • Alvarez, E.1    Rodiño-Janeiro, B.K.2    Ucieda-Somoza, R.3
  • 16
    • 0343048978 scopus 로고    scopus 로고
    • Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation
    • A.H. Wagner, T. Köhler, and U. Rückschloss Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation Arterioscler. Thromb. Vasc. Biol. 20 2000 61 69 (Pubitemid 30048347)
    • (2000) Arteriosclerosis, Thrombosis, and Vascular Biology , vol.20 , Issue.1 , pp. 61-69
    • Wagner, A.H.1    Kohler, T.2    Ruckschloss, U.3    Just, I.4    Hecker, M.5
  • 17
    • 77955434278 scopus 로고    scopus 로고
    • New pathways to renal damage: Role of ADMA in retarding renal disease progression
    • S. Ueda, S. Yamagishi, and S. Okuda New pathways to renal damage: role of ADMA in retarding renal disease progression J. Nephrol. 23 2010 377 386
    • (2010) J. Nephrol. , vol.23 , pp. 377-386
    • Ueda, S.1    Yamagishi, S.2    Okuda, S.3
  • 18
    • 65249184373 scopus 로고    scopus 로고
    • Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes
    • E. Schepers, G. Glorieux, and A. Dhondt Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes Nephrol. Dial. Transplant. 24 2009 1429 1435
    • (2009) Nephrol. Dial. Transplant. , vol.24 , pp. 1429-1435
    • Schepers, E.1    Glorieux, G.2    Dhondt, A.3
  • 19
    • 0037143637 scopus 로고    scopus 로고
    • Impaired nitric oxide synthase pathway in diabetes mellitus: Role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase
    • DOI 10.1161/01.CIR.0000027109.14149.67
    • K.Y. Lin, A. Ito, and T. Asagami Impaired nitric oxide synthase pathway in diabetes mellitus role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase Circulation 106 2002 987 992 (Pubitemid 34925335)
    • (2002) Circulation , vol.106 , Issue.8 , pp. 987-992
    • Lin, K.Y.1    Ito, A.2    Asagami, T.3    Tsao, P.S.4    Adimoolam, S.5    Kimoto, M.6    Tsuji, H.7    Reaven, G.M.8    Cooke, J.P.9
  • 20
    • 19544377337 scopus 로고    scopus 로고
    • Pravastatin restores DDAH activity and endothelium-dependent relaxation of rat aorta after exposure to glycated protein
    • DOI 10.1097/01.fjc.0000159642.44523.7f
    • Q.F. Yin, and Y. Xiong Pravastatin restores DDAH activity and endothelium-dependent relaxation of rat aorta after exposure to glycated protein J. Cardiovasc. Pharmacol. 45 2005 525 532 (Pubitemid 40734572)
    • (2005) Journal of Cardiovascular Pharmacology , vol.45 , Issue.6 , pp. 525-532
    • Yin, Q.-F.1    Xiong, Y.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.